Clinical Trial

Study of AT-587 in Healthy Subjects

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study will assess the safety, tolerability and pharmacokinetics (PK) of AT-587 in healthy subjects
Trial Details
NCT Number NCT07728487
Lead Sponsor Atea Pharmaceuticals, Inc.
Conditions Hepatitis E
Enrollment 62 participants
Start Date 2026-07-13
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-27